Similar articles for PMID: 16832072

Year	Number of Results
1994	1
1995	2
1996	1
1997	1
1998	1
1999	5
2000	7
2001	3
2002	7
2003	6
2004	10
2005	8
2006	16
2007	13
2008	15
2009	11
2010	4
2011	2
2012	1
2013	3
2014	4
2015	1
2017	2
2018	1
2019	4
2020	2
2021	1
2024	0

1

Neuroprotective agents for clinical trials in ALS: a systematic assessment.

Traynor BJ, Bruijn L, Conwit R, Beal F, O'Neill G, Fagan SC, Cudkowicz ME. Traynor BJ, et al. Neurology. 2006 Jul 11;67(1):20-7. doi: 10.1212/01.wnl.0000223353.34006.54. Neurology. 2006. PMID: 16832072 Review.

2

Selecting promising ALS therapies in clinical trials.

Cheung YK, Gordon PH, Levin B. Cheung YK, et al. Neurology. 2006 Nov 28;67(10):1748-51. doi: 10.1212/01.wnl.0000244464.73221.13. Neurology. 2006. PMID: 17130405 Review.

3

Neuroprotective agents for clinical trials in ALS: systematic assessment.

Burke WJ. Burke WJ. Neurology. 2007 Feb 27;68(9):709; author reply 710. doi: 10.1212/01.wnl.0000258815.56062.43. Neurology. 2007. PMID: 17325287 No abstract available.

4

Toward more efficient clinical trials for amyotrophic lateral sclerosis.

Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG. Cudkowicz ME, et al. Amyotroph Lateral Scler. 2010 May 3;11(3):259-65. doi: 10.3109/17482960903358865. Amyotroph Lateral Scler. 2010. PMID: 19961263 Review.

5

A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.

Gordon PH. Gordon PH. Muscle Nerve. 2009 Jun;39(6):858-60. doi: 10.1002/mus.21354. Muscle Nerve. 2009. PMID: 19382169

6

[What are the etiological medical therapies in amyotrophic lateral sclerosis?].

Dib M. Dib M. Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S215-4S219. Rev Neurol (Paris). 2006. PMID: 17128114 French.

7

[Minocycline for the treatment of amyotrophic lateral sclerosis: neuroprotector or neurotoxin? Reflections on another failure of translational medicine].

Gámez J. Gámez J. Neurologia. 2008 Oct;23(8):484-93. Neurologia. 2008. PMID: 18802797 Spanish.

8

Outcome measures for early phase clinical trials.

Gordon PH, Cheng B, Montes J, Doorish C, Albert SM, Mitsumoto H. Gordon PH, et al. Amyotroph Lateral Scler. 2007 Oct;8(5):270-3. doi: 10.1080/17482960701547958. Amyotroph Lateral Scler. 2007. PMID: 17852017 Clinical Trial.

9

Arimoclomol: a potential therapy under development for ALS.

Lanka V, Wieland S, Barber J, Cudkowicz M. Lanka V, et al. Expert Opin Investig Drugs. 2009 Dec;18(12):1907-18. doi: 10.1517/13543780903357486. Expert Opin Investig Drugs. 2009. PMID: 19938902 Review.

10

[The advance in the research and therapeutic trials of amyotrophic lateral sclerosis].

Moriwaka F, Tashiro K. Moriwaka F, et al. Rinsho Shinkeigaku. 2000 Dec;40(12):1258-60. Rinsho Shinkeigaku. 2000. PMID: 11464472 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year